Hexamethylene bisacetamide and cis-platin stimulate the expression from the HIV-1 long terminal repeat sequence in human MCF-7 cells

In Vivo. 1992 Mar-Apr;6(2):145-9.

Abstract

We have employed a recombinant plasmid pBHIV-1 carrying the Long Terminal Repeat sequences (LTR) of the Human Immunodeficiency Virus (HIV-1) linked to the reporter chloramphenicol acetyl transferase (CAT) gene and to the aminoglycoside phosphotransferase (aph) gene as a selectable marker. We have introduced pBHIV-1 DNA in human breast cancer MCF-7 cells and obtained the MCF-7HIV-1 cell line, resistant to geneticin. We have studied the effect of hexamethylene-bisacetamide (HMBA), cis-platin, interferon-aB, dexamethasone and tamoxifen on the LTR regulated CAT activity in MCF-7HIV-1 cells. It was found that HMBA and cis-platin stimulated CAT activity, whereas interferon-aB, dexamethasone and tamoxifen had no significant effect.

MeSH terms

  • Acetamides / pharmacology*
  • Breast Neoplasms / pathology
  • Cisplatin / pharmacology*
  • Dexamethasone / pharmacology
  • Gene Expression Regulation, Viral / drug effects*
  • HIV Long Terminal Repeat / drug effects*
  • HIV-1 / drug effects*
  • Humans
  • Interferon Type I / pharmacology
  • Interferon-alpha
  • Neoplasms, Hormone-Dependent / pathology
  • Recombinant Proteins
  • Stimulation, Chemical
  • Tamoxifen / pharmacology
  • Tumor Cells, Cultured / drug effects

Substances

  • Acetamides
  • Interferon Type I
  • Interferon-alpha
  • Recombinant Proteins
  • interferon-alpha 8
  • Tamoxifen
  • Dexamethasone
  • hexamethylene bisacetamide
  • Cisplatin